BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25034231)

  • 1. Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathways.
    Pandey MK; Kale VP; Song C; Sung SS; Sharma AK; Talamo G; Dovat S; Amin SG
    Exp Hematol; 2014 Oct; 42(10):883-96. PubMed ID: 25034231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
    Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.
    Chua AW; Hay HS; Rajendran P; Shanmugam MK; Li F; Bist P; Koay ES; Lim LH; Kumar AP; Sethi G
    Biochem Pharmacol; 2010 Nov; 80(10):1553-62. PubMed ID: 20699088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia.
    Lu DY; Tang CH; Yeh WL; Wong KL; Lin CP; Chen YH; Lai CH; Chen YF; Leung YM; Fu WM
    Eur J Pharmacol; 2009 Jun; 613(1-3):146-54. PubMed ID: 19285061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway.
    Ahn KS; Sethi G; Chaturvedi MM; Aggarwal BB
    Int J Cancer; 2008 Oct; 123(8):1733-40. PubMed ID: 18688862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.
    Sung B; Cho SG; Liu M; Aggarwal BB
    Int J Cancer; 2011 Nov; 129(9):2062-72. PubMed ID: 21170936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvianolic acid B inhibits SDF-1α-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor.
    Pan CH; Chen CW; Sheu MJ; Wu CH
    Vascul Pharmacol; 2012; 56(1-2):98-105. PubMed ID: 22166584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4
    Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
    Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
    Menu E; Asosingh K; Indraccolo S; De Raeve H; Van Riet I; Van Valckenborgh E; Vande Broek I; Fujii N; Tamamura H; Van Camp B; Vanderkerken K
    Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α.
    Zhi Y; Lu H; Duan Y; Sun W; Guan G; Dong Q; Yang C
    Int J Mol Med; 2015 Feb; 35(2):349-57. PubMed ID: 25503960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
    Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
    Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Protein C23 on the Cell Surface Plays an Important Role in Activation of CXCR4 Signaling in Glioblastoma.
    Dai C; Lv S; Shi R; Ding J; Zhong X; Song H; Ma X; Fan J; Sun B; Wang R; Ma W
    Mol Neurobiol; 2015 Dec; 52(3):1521-1526. PubMed ID: 25367885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.
    Reuter S; Prasad S; Phromnoi K; Kannappan R; Yadav VR; Aggarwal BB
    Mol Cancer Res; 2010 Oct; 8(10):1425-36. PubMed ID: 20826545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
    Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
    Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells.
    Tang CH; Chuang JY; Fong YC; Maa MC; Way TD; Hung CH
    Carcinogenesis; 2008 Aug; 29(8):1483-92. PubMed ID: 18310089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.